126 results on '"Cobelli F"'
Search Results
2. How to perform the optimal renal biopsy: A machine learning-based indication
3. Does the PRECISE score improves PI-RADS ability to predict grade reclassification in men on active surveillance for early prostate cancer?
4. Assessing epigenetic features associated with lymph node metastases in prostate cancer
5. PSMA radio-guided surgery to detect nodal metastases in prostate cancer patients undergoing robot-assisted radical prostatectomy and extended pelvic lymph node dissection: Updated results of a planned interim analysis of a prospective phase 2 study
6. A novel PRECISE implemented predictive model to assess the risk of long-term disease reclassification in men on active surveillance. Results from a large, single institution series
7. First results of NURE-Combo: A phase 2 study of neoadjuvant Nivolumab (NIVO) and Nab-Paclitaxel (ABX) followed by postsurgical adjuvant NIVO in patients (pts) with Muscle-Invasive Bladder Cancer (MIBC)
8. The role of artificial intelligence for the detection of clinically significant prostate cancer at multiparametric magnetic resonance imaging
9. Optimizing the number of systematic cores during MRI target biopsy. Preliminary results from the prospective, paired-cohort SCOT Trial
10. Towards a tailored use of PSA density to decide when to avoid prostate biopsy in men with PIRADS 3 lesions according to the location of the index lesion at mp-MRI. Results of a large, multi-institutional series
11. How can we reduce the rates of false positive findings at mpMRI? The pivotal role of urologist expertise assessed in a large, single center series
12. Concordance of renal sinus or calyces invasion between preoperative imaging and final pathology after surgery for kidney cancer
13. Oncologic outcomes of patients with incidental prostate cancer: Can we rely on multiparametric mri to exclude aggressive prostate cancer?
14. Is there an impact of the center performing baseline multiparametric MRI on active surveillance outcomes in prostate cancer patients?
15. Utility of pre- and post-pembrolizumab (Pembro) Vesical Imaging–Reporting and Data System (VI-RADS) to predict the pathological response in muscle-invasive urothelial bladder cancer (MIBC): An analysis of the PURE-01 cohort
16. Does previous prostatic surgery affect the accuracy of multiparametric MRI in detecting clinically significant prostate cancer? Results from a single center, high volume series
17. Has the introduction of mpMRI in the diagnostic pathway of prostate cancer led to improved oncological outcomes after radical prostatectomy? Result from a large single-institutional series
18. Neglected lymph nodal metastases in patients with renal cancer: When to extend the anatomical template of lymph node dissection during nephrectomy
19. Prostate cancers detected at multi-parametric MRI targeted versus systematic biopsies: are they equal? Results from a large multi-institutional series
20. Pancreatic metastases after surgery for renal cell carcinoma
21. Precision surgery for Von Hippel-Lindau renal cell carcinoma
22. Imaging intensity after surgery for clear cell renal cell carcinoma
23. Does a positive multi-parametric MRI always warrant prostate biopsy? The importance of integrating clinical and imaging data based on a large, multi-institutional series
24. The anatomical location of lymphadenopathies at imaging predicts the risk of lymph node invasion at final pathology in patients with renal cell carcinoma
25. When to de-intensify oncologic surveillance scheme for non-clear cell renal cell carcinoma
26. Systematic definition of treatment modality and clinical outcomes reporting system in case of surgical treatment for Von Hippel-Lindau renal cell carcinoma
27. Detection of clinically significant prostate cancer in mpMRI visible lesions: Size matters. Results from a large, two-institutional series
28. The risk of Von Hippel-Lindau disease according to individual sporadic cancer in a multidisciplinary program: External validation of the VHL Alliance guidelines for genetic referral
29. A1083 - Assessing epigenetic features associated with lymph node metastases in prostate cancer
30. A0901 - First results of NURE-Combo: A phase 2 study of neoadjuvant Nivolumab (NIVO) and Nab-Paclitaxel (ABX) followed by postsurgical adjuvant NIVO in patients (pts) with Muscle-Invasive Bladder Cancer (MIBC)
31. A0818 - A novel PRECISE implemented predictive model to assess the risk of long-term disease reclassification in men on active surveillance. Results from a large, single institution series
32. A0812 - Does the PRECISE score improves PI-RADS ability to predict grade reclassification in men on active surveillance for early prostate cancer?
33. A0716 - Does the accuracy of PSA density change according to prostate volume? Assessing the diagnostic accuracy at the extreme values of prostate volume in a large single institution series
34. A0469 - How to perform the optimal renal biopsy: A machine learning-based indication
35. A0436 - PSMA radio-guided surgery to detect nodal metastases in prostate cancer patients undergoing robot-assisted radical prostatectomy and extended pelvic lymph node dissection: Updated results of a planned interim analysis of a prospective phase 2 study
36. A0055 - Optimizing the number of systematic cores during MRI target biopsy. Preliminary results from the prospective, paired-cohort SCOT Trial
37. P329 - How can we reduce the rates of false positive findings at mpMRI? The pivotal role of urologist expertise assessed in a large, single center series
38. P311 - Towards a tailored use of PSA density to decide when to avoid prostate biopsy in men with PIRADS 3 lesions according to the location of the index lesion at mp-MRI. Results of a large, multi-institutional series
39. P145 - Preoperative or intraoperative renal biopsy increases the accuracy in predicting lymph node invasion in patients with renal cell carcinoma
40. P144 - Renal biopsy does not affect mortality in renal mass patients when confronted with upfront surgery: A propensity score adjusted analysis
41. P128 - Surveillance interruption and need for active treatment in Von Hippel-Lindau disease: implications for clinical management and trial design
42. P126 - Diagnostic performance of multiparametric magnetic resonance imaging before renal biopsy using Clear Cell Likelihood Score (ccLS)
43. P046 - The role of artificial intelligence for the detection of clinically significant prostate cancer at multiparametric magnetic resonance imaging
44. The learning curve of mpMRI targeted biopsy for the detection of clinically significant prostate cancer is related to the characteristics of the index lesion
45. Development and external validation of a novel tool predicting lymph node invasion in patients with prostate cancer detected at targeted-biopsies
46. External validation of the VHL alliance guidelines for VHL genetic testing in patients diagnosed with renal cell carcionoma
47. Optimizing the number of systematic cores during an MRI target biopsy: Preliminary results from the prospective, single center SCOT Trial (NCT 04183699)
48. Should we routinely recommend a central review of magnetic resonance imaging of the prostate in men with positive mp-MRI? Implication for targeted biopsies
49. Development of novel criteria to identify the optimal candidates for active surveillance among men with low-risk prostate cancer and a positive family history. Results from a large, single institution series
50. Positive predictive value of mpmri in men under active surveillance: Can the biopsy history influence radiological assessment?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.